LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 1 of 15: Cell count and relative growth within biological replicate 1. - Dataset (ID:20237)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Replicate | Assay Well | Timepoint | Timepoint Unit | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Relative Growth Rate After Treatment |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
SK-BR-3 | GSK1059615 | 0.12 | uM | LJP6 | 3 | C05 | 72 | hr | 1476 | 2841 | 3694 | 0.7691 | 0.6153 |
SK-BR-3 | GSK1904529A | 0.12 | uM | LJP6 | 1 | H23 | 72 | hr | 1476 | 2865 | 3694 | 0.7756 | 0.6261 |
SK-BR-3 | GSK1904529A | 0.12 | uM | LJP6 | 2 | H23 | 72 | hr | 1476 | 3255 | 3694 | 0.8812 | 0.8020 |
SK-BR-3 | GSK1904529A | 0.12 | uM | LJP6 | 3 | H23 | 72 | hr | 1476 | 3363 | 3694 | 0.9104 | 0.8507 |
SK-BR-3 | Omipalisib | 0.12 | uM | LJP6 | 1 | N05 | 72 | hr | 1476 | 1321 | 3694 | 0.3576 | -0.0702 |
SK-BR-3 | Omipalisib | 0.12 | uM | LJP6 | 2 | N05 | 72 | hr | 1476 | 1511 | 3694 | 0.4090 | 0.0155 |
SK-BR-3 | Omipalisib | 0.12 | uM | LJP6 | 3 | N05 | 72 | hr | 1476 | 1444 | 3694 | 0.3909 | -0.0148 |
SK-BR-3 | GSK 690693 | 0.12 | uM | LJP5 | 1 | F23 | 72 | hr | 1476 | 2680 | 3694 | 0.7255 | 0.5427 |
SK-BR-3 | GSK 690693 | 0.12 | uM | LJP5 | 2 | F23 | 72 | hr | 1476 | 2668 | 3694 | 0.7222 | 0.5373 |
SK-BR-3 | GSK 690693 | 0.12 | uM | LJP5 | 3 | F23 | 72 | hr | 1476 | 2430 | 3694 | 0.6578 | 0.4299 |
SK-BR-3 | GW843682X | 0.12 | uM | LJP6 | 1 | B17 | 72 | hr | 1476 | 2222 | 3694 | 0.6015 | 0.3361 |
SK-BR-3 | GW843682X | 0.12 | uM | LJP6 | 2 | B17 | 72 | hr | 1476 | 2166 | 3694 | 0.5864 | 0.3109 |
SK-BR-3 | GW843682X | 0.12 | uM | LJP6 | 3 | B17 | 72 | hr | 1476 | 2126 | 3694 | 0.5755 | 0.2928 |
SK-BR-3 | HG-5-113-01 | 0.12 | uM | LJP5 | 1 | B11 | 72 | hr | 1476 | 2744 | 3694 | 0.7428 | 0.5715 |
SK-BR-3 | HG-5-113-01 | 0.12 | uM | LJP5 | 2 | B11 | 72 | hr | 1476 | 2886 | 3694 | 0.7813 | 0.6356 |
SK-BR-3 | HG-5-113-01 | 0.12 | uM | LJP5 | 3 | B11 | 72 | hr | 1476 | 2916 | 3694 | 0.7894 | 0.6491 |
SK-BR-3 | HG-5-88-01 | 0.12 | uM | LJP6 | 1 | A23 | 72 | hr | 1476 | 2814 | 3694 | 0.7618 | 0.6031 |
SK-BR-3 | HG-5-88-01 | 0.12 | uM | LJP6 | 2 | A23 | 72 | hr | 1476 | 2984 | 3694 | 0.8078 | 0.6798 |
SK-BR-3 | HG-5-88-01 | 0.12 | uM | LJP6 | 3 | A23 | 72 | hr | 1476 | 3104 | 3694 | 0.8403 | 0.7339 |
SK-BR-3 | Imatinib | 0.12 | uM | LJP6 | 1 | N17 | 72 | hr | 1476 | 3499 | 3694 | 0.9472 | 0.9120 |
SK-BR-3 | Imatinib | 0.12 | uM | LJP6 | 2 | N17 | 72 | hr | 1476 | 4034 | 3694 | 1.0920 | 1.1533 |
SK-BR-3 | Imatinib | 0.12 | uM | LJP6 | 3 | N17 | 72 | hr | 1476 | 3992 | 3694 | 1.0807 | 1.1344 |
SK-BR-3 | JNK-9L | 0.12 | uM | LJP6 | 1 | K23 | 72 | hr | 1476 | 2617 | 3694 | 0.7084 | 0.5143 |
SK-BR-3 | JNK-9L | 0.12 | uM | LJP6 | 2 | K23 | 72 | hr | 1476 | 2675 | 3694 | 0.7241 | 0.5404 |
SK-BR-3 | JNK-9L | 0.12 | uM | LJP6 | 3 | K23 | 72 | hr | 1476 | 2855 | 3694 | 0.7729 | 0.6216 |